FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular, to an antibody specific to human IL-11 and IL-11 of model animals, such as the crab-eating macaque, or to an antigen-binding fragment thereof, as well as to a conjugate containing said antibody.
EFFECT: invention is effective for determining the concentration of IL-11 in human samples and samples of model animals, such as the crab-eating macaque.
3 cl, 2 dwg, 3 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC ANTIBODY SPECIFIC TO INTERLEUKIN-11, INHIBITING SIGNALING THROUGH ITS RECEPTOR, AND METHOD FOR ITS USE FOR THE TREATMENT OF PATIENTS | 2019 |
|
RU2753973C2 |
ANTIBODIES SPECIFIC TO CD47 AND PD-L1 | 2020 |
|
RU2779652C2 |
HUMANIZED ANTIBODIES AND ANTIBODIES WITH MATURE AFFINITY AGAINST FcRH5 AND METHODS FOR THEIR APPLICATION | 2016 |
|
RU2748943C2 |
MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS TO CD20 | 2018 |
|
RU2724469C2 |
ISOLATED BISPECIFIC ANTIBODY THAT SPECIFICALLY BINDS TO CD47 AND PD-L1 | 2021 |
|
RU2815823C2 |
MONOCLONAL ANTIBODY WHICH SPECIFICALLY BINDS GITR | 2019 |
|
RU2734432C1 |
ANTIBODY MOLECULES THAT BIND PD-L1 AND CD137 | 2019 |
|
RU2826084C2 |
PD1 ANTIBODIES AND THEIR APPLICATION METHODS | 2016 |
|
RU2746409C1 |
PROTEIN BOUND WITH HUMAN GLYCOPROTEIN, COMPOSITION, PHARMACEUTICAL COMPOSITION, EXPRESSION VECTOR | 2016 |
|
RU2773819C2 |
ANTI-PD-1 ANTIBODY AND USE THEREOF | 2017 |
|
RU2739610C1 |
Authors
Dates
2021-12-28—Published
2020-03-23—Filed